Trouver une ressource
Consultez notre collection d’informations et de ressources organisées!
*Plus de ressources sont disponibles en anglais.
The Case for Heroin-Assisted Treatment in Canada
Rapport
This report outlines the case for heroin-assisted treatment in Canada. Heroin-Assisted Treatment, or HAT, is a medical intervention that provides pre…
Source: Pivot Legal SocietyFormat: PDF
Publié : 2017
Sujets : Approches axées sur l’équité, Traitement et réduction des méfaits, Substances spécifiques
Scale up of Managed Alcohol Programs
Fiche d’information/infographie
In this bulletin, the authors provide some beginning guidance and suggestions for organizations looking to initiate or scale up a MAP. There is subst…
Source: Canadian Institute for Substance Use Research (CISUR)Format: PDF
Publié : 2020
Sujets : Réduction des méfaits, Programme de gestion de l’alcoolisme, Substances spécifiques
An Evidence Brief: Supervised Consumption Sites are Necessary Public Health Services
Article universitaire
This brief reviews the evidence on supervised consumption sites, with a focus on effectiveness and community impact. A wealth of evidence suggests th…
Source: Canadian Institute for Substance Use Research (CISUR)Format: PDF
Publié : 2020
Sujets : Réduction des méfaits, Sites de consommation supervisée
Interventions to Reduce Stigma Among Health Care Providers Working with Substance Users
Article universitaire
This rapid response explores the question: "What are effective interventions for reducing stigma among health care providers who work with substance …
Source: The Ontario HIV Treatment Network (OHTN)Format: PDF
Publié : 2018
Sujets : Déterminants de la santé, Lutter contre la stigmatisation structurelle
Life in Recovery from Addiction in Canada
Rapport
The Canadian Centre on Substance Use and Addiction (CCSA) together with their partners conducted the first-ever nationwide survey of individuals in r…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2017
Sujets : Approches axées sur l’équité, Rétablissement et résilience
Cannabis (Canadian Drug Summary)
Rapport
This report provides an overview of key data and information about cannabis before and after legalization and regulation, as well as on new classes o…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2020
Sujets : Surveillance nationale, Substances spécifiques
Prescription Opioids (Canadian Drug Summary)
Rapport
This report summarizes data on the use of prescription opioids, including information on associated harms and effects, legal status, costs, hospitali…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2020
Sujets : Surveillance nationale, Substances spécifiques
Sedatives (Canadian Drug Summary)
Rapport
This report summarizes data on the prescription and non-medical use of sedatives, including information on the effects, associated harms, and availab…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2019
Sujets : Surveillance nationale, Substances spécifiques
Prescription Stimulants (Canadian Drug Summary)
Rapport
This report summarizes data on the use and misuse of prescription stimulants, including the harms and effects, legal status, and access to treatment…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2019
Sujets : Surveillance nationale, Substances spécifiques
Ecstasy or Molly (MDMA) (Canadian Drug Summary)
Rapport
This report summarizes research on the use of MDMA (street named ecstasy or molly), a synthetically derived chemical used recreationally. Less than 1…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2017
Sujets : Surveillance nationale, Substances spécifiques